Trials / Terminated
TerminatedNCT02564549
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca
Multiparametric MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Cancer (MAVERICK)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Phase II non-inferiority randomized trial of annual systematic biopsies versus mpMRI and targeted biopsies for men with low risk prostate cancer on active surveillance with any volume Gleason's Score 6, but no prior MRI imaging of the prostate.
Detailed description
This is an unblinded, randomized trial of TRUS biopsy-based active surveillance versus mpMRI-based active surveillance. Patients on the TRUS biopsy-based arm will undergo annual systematic biopsies without any MRI staging or guidance. Patients on the mpMRI- based arm will undergo annual mpMRI surveillance imaging, with image-guided targeted biopsies only as indicated by radiographic findings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TRUS-guided biopsy | Patients on the TRUS biopsy-based arm will undergo annual systematic biopsies without any MRI staging or guidance. |
| PROCEDURE | mpMRI with targeted biopsy | Patients on the mpMRI- based arm will undergo annual mpMRI surveillance imaging, with image-guided targeted biopsies only as indicated by radiographic findings. |
Timeline
- Start date
- 2015-10-05
- Primary completion
- 2016-06-28
- Completion
- 2017-10-13
- First posted
- 2015-09-30
- Last updated
- 2017-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02564549. Inclusion in this directory is not an endorsement.